In recent years, the wealth of basic science research supporting resveratrol's potential to treat, delay, and even prevent age-related chronic diseases has led to a number of human clinical trials.
In recent years, the wealth of basic science research supporting RS Vs potential to treat, delay, and even prevent age-related chronic diseases has led to a number of human clinical trials.
About ten years ago, David Laibson published a paper on "hyperbolic discounting," which suggested that people treat immediate rewards differently from the way they treat delayed rewards, preferring the former in a manner that simple rational-choice models can't explain.
Induced hypertension is often used to treat delayed cerebral ischaemia (DCI) after aneurysmal subarachnoid haemorrhage (aSAH) by trying to augment cerebral blood flow (CBF) [1].
In Group B (n=11) EF was removed after 4 6 months and replaced by an intramedullary nail in order to treat delayed consolidation (n=5) or loose fixator screws (n=6).
Metoclopramide is extensively used as an intravenous prokinetic drug to treat delayed gastric emptying and to facilitate early enteral feeding.
Thermal tactile stimulation therapy, an established technique to treat delayed pharyngeal swallow, confirms the influence of sensory perception on swallowing (Lazzara et al., 1986).
The circadian model suggests that interventions should aim to synchronize the circadian clock of children presenting with ADHD to the environmental light dark cycle in order to effectively treat delayed sleep onset and delayed bedtimes.
As previously mentioned, intravenous metoclopramide is frequently used to treat delayed gastric emptying and to facilitate early enteral feeding, and its off-label use can be sufficiently supported by documented evidence.
Among the multidisciplinary approaches explored to treat delayed union and nonunion fractures, the majority of studies employ the use of invasive procedures, such as surgical debridement, bone grafting and harvesting, or local injections [ 22, 23], and hence, these procedures have been primarily examined in established nonunions.
Although patients with these complications are frequently seen in eye clinics and the molecular mechanisms to revert them are known from translational studies, there are no commercially available products to effectively treat delayed corneal re-epithelization without inducing adverse side effects [ 1, 2].
